EP2247618A1
Ferroportin antibodies and methods of use
Abstract
This record has no abstract on file.
Term
2.3 yearsto projected expiry
Projected expiry 23 January 2029, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| See references of WO 2009094551A1 | Non-patent | Search report |
21 members in 8 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 23693P | United States of America | – | |
| 2369308 | United States of America | P | |
| 121729P | United States of America | – | |
| 12172908 | United States of America | P | |
| 2009031851 | United States of America | W |
Members21
| Document | Office | Kind | |
|---|---|---|---|
| AU2009206306A1 | Australia | A1 | |
| CA2711826A1 | Canada | A1 | |
| WO2009094551A1 | World Intellectual Property Organization (WIPO) | A1 | |
| MX2010008096A | Mexico | A | |
| EP2247618A1This record | European Patent Office (EPO) | A1 | |
| JP2011510629A | Japan | A | |
| US2011274691A1 | United States of America | A1 | |
| EP2574628A1 | European Patent Office (EPO) | A1 | |
| AU2009206306B2 | Australia | B2 | |
| AU2013206183A1 | Australia | A1 | |
| EP2247618B1 | European Patent Office (EPO) | B1 | |
| ES2500066T3 | Spain | T3 | |
| EP2803675A2 | European Patent Office (EPO) | A2 | |
| EP2803675A3 | European Patent Office (EPO) | A3 | |
| JP5701064B2 | Japan | B2 | |
| EP2574628B1 | European Patent Office (EPO) | B1 | |
| US9175078B2 | United States of America | B2 | |
| US2016083470A1 | United States of America | A1 | |
| AU2013206183B2 | Australia | B2 | |
| US9688759B2 | United States of America | B2 | |
| CA2711826C | Canada | C |
75 legal events, as 10 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Invalidated european patentMG4D | MG4D | LT | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| New agentNV | NV | CH | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2247618
- Application
- 97040661
Titles3
- German
- FERROPORTIN-ANTIKÖRPER UND ANWENDUNGSVERFAHREN
- English
- FERROPORTIN ANTIBODIES AND METHODS OF USE
- French
- ANTICORPS ANTI-FERROPORTINE ET PROCÉDÉS D'UTILISATION
Classification
- CPC, 25
- C07K16/28
- A61K38/1816
- A61K2039/505
- A61P3/00
- A61P3/10
- A61P7/00
- A61P7/06
- A61P9/04
- A61P9/10
- A61P13/12
- A61P19/02
- A61P29/00
- A61P35/00
- A61P37/02
- A61P43/00
- C07K2317/21
- C07K2317/34
- C07K2317/56
- C07K2317/565
- C07K2317/70
- G01N33/6872
- G01N33/90
- G01N2800/00
- A61K39/3955
- C07K2317/76
- IPC, 4
- C07K16 28
- A61K39 395
- A61P7 06
- G01N33 577
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- Serbia